On the Record · Teva Pharmaceutical Industries
Teva Pharmaceutical Industries competitors, on the record
The companies Teva Pharmaceutical Industries names as competitors in its annual reports, 2023 to 2025, and the companies that name Teva Pharmaceutical Industries, each with the sentence and the filing.
Who Teva Pharmaceutical Industries names
| Company | Named in |
|---|---|
| Azurity Pharmaceuticals | 2025 |
| Eagle | 2025 |
In its own words
Azurity Pharmaceuticals, Eagle
Word for word“BENDEKA faces direct competition from Belrapzo ® (a ready-to-dilute bendamustine hydrochloride product from Eagle) and from Vivimusta ® (a bendamustine hydrochloride injection from Azurity Pharmaceuticals).” 10-K for 2025
Who names Teva Pharmaceutical Industries
Companies whose own annual reports name Teva Pharmaceutical Industries as a competitor.
Word for word“Our principal competitors in the generic and biosimilar pharmaceutical market include Teva Pharmaceutical Industries Ltd., Viatris Inc., Sandoz Group, Pfizer Inc., Fresenius Kabi KGaA, Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd., Amphastar Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Inc., Zydus Pharmaceuticals USA Inc., and Aurobindo Pharma Limited.” 10-K for 2025
Word for word“Our major competitors, including Teva Pharmaceutical Industries Limited, Viatris, Sandoz, Aurobindo Pharma Limited and Amneal, among others, vary by product.” 10-K for 2024
Word for word“Our major competitors, including Teva Pharmaceutical Industries Limited, Viatris, Sandoz, Aurobindo Pharma Limited and Amneal, among others, vary by product.” 10-K for 2023
Read from Teva Pharmaceutical Industries’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-03. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.